Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon
arrow-right
Use Icons In The App

Try a synonym, or sign up to request an icon from the app.

Fc receptor (CD32)

Fc receptor (CD32) - Editable icon of CD32 Fc receptor with α-chain of two extracellular Ig-like domains and intracellular ITAM or ITIM domain
[{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7fc/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7fc/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7fb/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7fb/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7fa/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7fa/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f9/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f9/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f8/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f8/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f7/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f7/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f6/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f6/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f5/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f5/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f4/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f4/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f3/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f3/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f2/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f2/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f1/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f1/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7f0/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7f0/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ef/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ef/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ee/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ee/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ed/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ed/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ec/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ec/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7eb/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7eb/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7ea/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7ea/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e9/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e9/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e8/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e8/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e7/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e7/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e6/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e6/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e5/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e5/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e4/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e4/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e3/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e3/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e2/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e2/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e1/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e1/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7e0/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7e0/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7df/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7df/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7de/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7de/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7dd/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7dd/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7dc/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7dc/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7db/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7db/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7da/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7da/5fe111953bc6e50027a6f7d8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fe112593bc6e50027a6f7d9/5fe111953bc6e50027a6f7d8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fe112593bc6e50027a6f7d9/5fe111953bc6e50027a6f7d8.png"}]
Keywords
CD32,Fc receptor,Fc region,FcγRIIA,FcγRII,α-chain,alpha chain,α chain,alpha-unit,Ig-like,Ig like,immunoglobin-like,ITAM,ITIM,CD32
Image types

Fc receptor (CD32) icon JPEG

Fc receptor (CD32) icon PNG

Fc receptor (CD32) icon SVG

Fc receptor (CD32) icon GIF

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Fc receptor (CD32) icon along with our library of more than 30,000 life science icons.
Can I use this icon in a BioRender figure or scientific illustration?
Yes, the Fc receptor (CD32) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.
Is the Fc receptor (CD32) icon customizable in BioRender?
Most icons in BioRender, including the Fc receptor (CD32) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.
How are scientists using the Fc receptor (CD32) icon in their work?
BioRender users often use the Fc receptor (CD32) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.
Can I export figures that include the Fc receptor (CD32) icon for publication or presentations?
Yes, figures containing the Fc receptor (CD32) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.
Is the Fc receptor (CD32) icon used in BioRender templates or poster layouts?
Many BioRender templates include icons like the Fc receptor (CD32) icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now